A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson’s Disease

<div>The forest plot: effects of G-Rg1 for decreasing the concentrations of IL-1<i>β</i> compared with control group. Note: G-Rg1: Ginsenosides-Rg1; IL-1<i>β</i>: cytokine interleukin-1<i>β</i>.</div>

Oxidative Medicine and Cellular Longevity

fig6

Figure 6

Figure 6: A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson’s Disease 